KURA: Kura Oncology Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Kura Oncology Inc (KURA).

OverviewDividends

$677.32M Market Cap.

As of 05/01/2025 5:00 PM ET (MRY) • Disclaimer

KURA Market Cap. (MRY)


KURA Shares Outstanding (MRY)


KURA Assets (MRY)


Total Assets

$760.16M

Total Liabilities

$346.52M

Total Investments

$502.93M

KURA Income (MRY)


Revenue

$53.88M

Net Income

-$173.98M

Operating Expense

$247.08M

KURA Cash Flow (MRY)


CF Operations

$134.32M

CF Investing

-$101.59M

CF Financing

$154.42M

KURA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$760,159,000 (69.32%)

$448,935,000 (-1.62%)

$456,306,000 (-14.56%)

$534,051,000 (-17.48%)

Assets Current

$744,829,000 (72.22%)

$432,481,000 (-3.12%)

$446,426,000 (-14.53%)

$522,289,000 (-18.05%)

Assets Non-Current

$15,330,000 (-6.83%)

$16,454,000 (66.54%)

$9,880,000 (-16.00%)

$11,762,000 (18.57%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$413,640,000 (4.12%)

$397,273,000 (-5.47%)

$420,278,000 (-17.04%)

$506,609,000 (-17.07%)

Property Plant & Equipment Net

$7,485,000 (-15.44%)

$8,852,000 (38.70%)

$6,382,000 (-22.60%)

$8,246,000 (-1.30%)

Cash & Equivalents

$224,462,000 (501.48%)

$37,318,000 (-27.96%)

$51,802,000 (-43.00%)

$90,882,000 (-72.10%)

Accumulated Other Comprehensive Income

$764,000 (160.11%)

-$1,271,000 (84.18%)

-$8,032,000 (-348.97%)

-$1,789,000 (-3989.13%)

Deferred Revenue

$253,906,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$502,933,000 (30.08%)

$386,639,000 (0.12%)

$386,183,000 (-9.62%)

$427,288,000 (38.81%)

Investments Current

$502,933,000 (30.08%)

$386,639,000 (0.12%)

$386,183,000 (-9.62%)

$427,288,000 (38.81%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$2,060,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$49,953,000 (47.98%)

$33,757,000 (55.28%)

$21,739,000 (7.66%)

$20,192,000 (-12.30%)

Accumulated Retained Earnings (Deficit)

-$895,422,000 (-24.12%)

-$721,439,000 (-26.83%)

-$568,808,000 (-31.37%)

-$432,968,000 (-43.13%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$16,594,000 (-3.52%)

$17,200,000 (22.65%)

$14,024,000 (103.99%)

$6,875,000 (-46.66%)

Debt Current

$4,488,000 (198.01%)

$1,506,000 (-35.03%)

$2,318,000 (2.43%)

$2,263,000 (-24.57%)

Debt Non-Current

$12,106,000 (-22.86%)

$15,694,000 (34.07%)

$11,706,000 (153.82%)

$4,612,000 (-53.36%)

Total Liabilities

$346,519,000 (570.74%)

$51,662,000 (43.39%)

$36,028,000 (31.29%)

$27,442,000 (-24.42%)

Liabilities Current

$78,712,000 (123.21%)

$35,263,000 (46.58%)

$24,057,000 (7.13%)

$22,455,000 (-13.71%)

Liabilities Non-Current

$267,807,000 (1533.07%)

$16,399,000 (36.99%)

$11,971,000 (140.04%)

$4,987,000 (-51.50%)

KURA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$53,883,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$77,111,000 (52.49%)

$50,569,000 (7.47%)

$47,053,000 (1.11%)

$46,537,000 (47.73%)

Research & Development Expense

$169,967,000 (47.50%)

$115,235,000 (24.16%)

$92,812,000 (9.55%)

$84,721,000 (40.27%)

Operating Expenses

$247,078,000 (49.02%)

$165,804,000 (18.55%)

$139,865,000 (6.56%)

$131,258,000 (42.83%)

Interest Expense

$1,619,000 (4.52%)

$1,549,000 (576.42%)

$229,000 (-44.69%)

$414,000 (-28.37%)

Income Tax Expense

$2,018,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$173,983,000 (-13.99%)

-$152,631,000 (-12.36%)

-$135,840,000 (-4.12%)

-$130,466,000 (-45.57%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$173,983,000 (-13.99%)

-$152,631,000 (-12.36%)

-$135,840,000 (-4.12%)

-$130,466,000 (-45.57%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$173,983,000 (-13.99%)

-$152,631,000 (-12.36%)

-$135,840,000 (-4.12%)

-$130,466,000 (-45.57%)

Weighted Average Shares

$86,161,000 (17.66%)

$73,229,000 (9.31%)

$66,990,000 (0.96%)

$66,352,000 (25.01%)

Weighted Average Shares Diluted

$86,161,000 (17.66%)

$73,229,000 (9.31%)

$66,990,000 (0.96%)

$66,352,000 (25.01%)

Earning Before Interest & Taxes (EBIT)

-$170,346,000 (-12.75%)

-$151,082,000 (-11.41%)

-$135,611,000 (-4.27%)

-$130,052,000 (-46.05%)

Gross Profit

$53,883,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$193,195,000 (-16.52%)

-$165,804,000 (-18.55%)

-$139,865,000 (-6.56%)

-$131,258,000 (-42.83%)

KURA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$101,590,000 (-753.02%)

$15,557,000 (-52.32%)

$32,627,000 (125.72%)

-$126,835,000 (-26.92%)

Net Cash Flow from Financing

$154,417,000 (62.92%)

$94,783,000 (145.77%)

$38,565,000 (1222.71%)

-$3,435,000 (-100.73%)

Net Cash Flow from Operations

$134,317,000 (207.61%)

-$124,824,000 (-13.41%)

-$110,062,000 (-5.27%)

-$104,551,000 (-49.72%)

Net Cash Flow / Change in Cash & Cash Equivalents

$187,144,000 (1392.07%)

-$14,484,000 (62.74%)

-$38,870,000 (83.45%)

-$234,821,000 (-178.39%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$101,118,000 (-743.04%)

$15,725,000 (-52.71%)

$33,253,000 (126.46%)

-$125,688,000 (-28.56%)

Capital Expenditure

-$472,000 (-180.95%)

-$168,000 (73.16%)

-$626,000 (45.42%)

-$1,147,000 (47.17%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$9,425,000 (219.90%)

-$7,861,000 (-3044.40%)

Issuance (Purchase) of Equity Shares

$154,417,000 (62.92%)

$94,783,000 (225.27%)

$29,140,000 (558.38%)

$4,426,000 (-99.06%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$33,897,000 (20.71%)

$28,082,000 (6.70%)

$26,318,000 (11.62%)

$23,579,000 (84.11%)

Depreciation Amortization & Accretion

$848,000 (-0.12%)

$849,000 (11.86%)

$759,000 (36.02%)

$558,000 (187.63%)

KURA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00%

-

-

-

Profit Margin

-322.90%

-

-

-

EBITDA Margin

-314.60%

-

-

-

Return on Average Equity (ROAE)

-38.50% (-6.06%)

-36.30% (-17.86%)

-30.80% (-28.87%)

-23.90% (3.63%)

Return on Average Assets (ROAA)

-30.20% (8.76%)

-33.10% (-14.14%)

-29.00% (-27.75%)

-22.70% (0.87%)

Return on Sales (ROS)

-316.10%

-

-

-

Return on Invested Capital (ROIC)

-37.20% (-1.92%)

-36.50% (-7.99%)

-33.80% (-27.07%)

-26.60% (28.30%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-4.31 (37.62%)

-6.91 (-13.09%)

-6.11 (13.99%)

-7.11 (63.22%)

Price to Sales Ratio (P/S)

13.93

-

-

-

Price to Book Ratio (P/B)

1.64 (-39.10%)

2.69 (36.10%)

1.98 (7.40%)

1.84 (-39.35%)

Debt to Equity Ratio (D/E)

0.84 (544.62%)

0.13 (51.16%)

0.09 (59.26%)

0.05 (-8.47%)

Earnings Per Share (EPS)

-2.02 (2.88%)

-2.08 (-2.46%)

-2.03 (-3.05%)

-1.97 (-16.57%)

Sales Per Share (SPS)

0.63 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

1.55 (190.98%)

-1.71 (-3.33%)

-1.65 (-3.70%)

-1.59 (-17.39%)

Book Value Per Share (BVPS)

4.8 (-11.50%)

5.42 (-13.53%)

6.27 (-17.83%)

7.63 (-33.67%)

Tangible Assets Book Value Per Share (TABVPS)

8.82 (43.91%)

6.13 (-10.00%)

6.81 (-15.37%)

8.05 (-33.99%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (42.86%)

-7 (-40.00%)

-5 (28.57%)

-7 (65.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-3.8 (45.95%)

-7.03 (-27.43%)

-5.52 (20.36%)

-6.93 (65.57%)

Asset Turnover

0.09 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

9.46 (-22.84%)

12.26 (-33.91%)

18.56 (-20.22%)

23.26 (-5.02%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$133,845,000 (207.08%)

-$124,992,000 (-12.92%)

-$110,688,000 (-4.72%)

-$105,698,000 (-46.80%)

Enterprise Value (EV)

$644,471,263 (-39.01%)

$1,056,716,956 (41.95%)

$744,428,423 (-17.05%)

$897,490,850 (-49.82%)

Earnings Before Tax (EBT)

-$171,965,000 (-12.67%)

-$152,631,000 (-12.36%)

-$135,840,000 (-4.12%)

-$130,466,000 (-45.57%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$169,498,000 (-12.82%)

-$150,233,000 (-11.41%)

-$134,852,000 (-4.14%)

-$129,494,000 (-45.74%)

Invested Capital

$473,579,000 (20.33%)

$393,554,000 (-0.23%)

$394,471,000 (-7.75%)

$427,589,000 (38.66%)

Working Capital

$666,117,000 (67.70%)

$397,218,000 (-5.95%)

$422,369,000 (-15.50%)

$499,834,000 (-18.23%)

Tangible Asset Value

$760,159,000 (69.32%)

$448,935,000 (-1.62%)

$456,306,000 (-14.56%)

$534,051,000 (-17.48%)

Market Capitalization

$677,322,263 (-36.58%)

$1,068,032,956 (28.65%)

$830,191,423 (-10.90%)

$931,780,850 (-49.69%)

Average Equity

$452,141,250 (7.52%)

$420,517,750 (-4.73%)

$441,410,000 (-19.19%)

$546,225,750 (51.42%)

Average Assets

$577,005,000 (25.20%)

$460,854,500 (-1.65%)

$468,576,000 (-18.52%)

$575,086,500 (46.87%)

Invested Capital Average

$457,378,500 (10.47%)

$414,011,250 (3.17%)

$401,284,000 (-18.00%)

$489,365,250 (103.69%)

Shares

77,763,750 (4.70%)

74,272,111 (11.02%)

66,896,972 (0.51%)

66,555,775 (17.37%)